Abstract
A novel coronavirus (SARS-CoV-2) first detected in Wuhan, China, has spread rapidly since December 2019, causing over 45,000 PCR confirmed infections and more than 1,000 fatalities (as of Feb 12, 2020). Imported cases and small transmission clusters have been reported globally. Early data suggest the virus transmits readily and a pandemic cannot be ruled out. Data from routine diagnostics show a strong and consistent seasonal variation of the four endemic coronaviruses (229E, HKU1, NL63, OC43). We use these data to explore the effect of seasonal variation in transmissibility on a potential SARS-CoV-2 pandemic. A model allowing for many subpopulations of different size with variable parameters of SARS-CoV-2 spread shows how a pandemic could unfold in 2020-2022. Simulations of different scenarios show that plausible parameters result in a peak in temperate regions of the Northern Hemisphere in winter 2020/2021. A smaller range of parameters suggests a peak in the first half of 2020 or two peaks of similar magnitude. Variation in transmission and migration rates can result in substantial variation in prevalence between regions.
While the uncertainty in parameters is large, the scenarios we explore show that transient reductions in the incidence rate might be due to a combination of seasonal variation and infection control efforts but do not necessarily mean the epidemic is contained. Seasonal forcing on SARS-CoV-2 should thus be taken into account in the further monitoring of the global transmission. The likely aggregated effect of seasonal variation, infection control measures, and transmission rate variation is a prolonged pandemic wave with lower prevalence at any given time, thereby providing a window of opportunity for better preparation of health care systems.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported in part by the National Science Foundation under Grant No. NSF PHY-1748958 (RAN during his visit to KITP).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data and script that generate the graphs are available in a dedicated github repository at github.com/neherlab/CoV_seasonality.
